Literature DB >> 19895648

Fatal liver injury associated with clopidogrel.

Sarrah Kastalli1, Sihem El Aïdli, Ahmed Zaïem, Hatem ben Abdallah, Riadh Daghfous.   

Abstract

Clopidogrel, an adenosine diphosphate receptor blocker, is widely used as an adjunctive antiplatelet therapy in acute coronary syndrome and percutaneous coronary stenting. It appears to be a safe drug with few occurrences of liver side-effects that usually resolved after drug withdrawal. We report a serious liver injury with fatal outcome in a 63-year-old man developed 19 days after starting clopidogrel for percutaneous coronary stenting.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19895648     DOI： 10.1111/j.1472-8206.2009.00791.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN： 0767-3981            Impact factor:   2.748


  4 in total

1.  Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.

Authors:  Alessia Omenetti; Liu Yang; Raul R Gainetdinov; Cynthia D Guy; Steve S Choi; Wei Chen; Marc G Caron; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

Review 2.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

3.  Clopidogrel-induced liver failure.

Authors:  Patrícia Howell Monteiro; Luís Dos Santos Pinheiro; Lourdes Alvoeiro; Margarida Lucas; Rui Mm Victorino
Journal:  JRSM Short Rep       Date:  2011-05-23

4.  Clopidogrel-Induced Severe Hepatitis: A Case Report and Literature Review.

Authors:  Hesam Keshmiri; Anuj Behal; Shawn Shroff; Charles Berkelhammer
Journal:  Case Reports Hepatol       Date:  2016-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.